Icu Medical signals 2026 results toward high end of $415M-$435M EBITDA and $8.60-$9 EPS range as logistics consolidation normalizes (NASDAQ:ICUI)
· seekingalpha.com
ICU Medical Q3 2026 earnings: record infusion growth, stronger margins, debt paydown, and guidance near the high end.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...